Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q3 2013 · 10-Q
Revenue$0.00$0.00— vs Q3 2012 Net Income-$4.68M-$4.68MN/M vs Q3 2012 EPS Diluted-$0.04-$0.04N/M vs Q3 2012 Operating Income-$888,150N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$783,470N/M ended Sep 30, 2013 · filed Nov 12, 2013 · 43 d after period end